4
Changes in Ownership
Immunome Inc. Filed Acc 0001209191-23-053982
Options or other derivatives
- Chief Medical Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lechleider Robert Chief Medical Officer | 2023-10-27 | Grant or award · Stock option (right to buy) | +400,000 | 400,000 | D: show line 1 in the form |
Loading xslF345X05/doc4.xml…